"Many medical conditions involve treatments that are only possible because transfusion is available as part of the treatment plan, from hemorrhage (such as trauma or obstetrical bleeding) to cancer care and organ transplants," Dr. Kirsten […]
SEATTLE, Dec. 29, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and […]
The company aims to close the gap between the results of preclinical studies and what actually happens in a clinical setting. Click here to view original post.
PORTLAND, Ore.: PORTLAND, Ore., Dec. 28, 2021 /PRNewswire/ — Phylos®, a modern crop science company developing advanced Cannabis and hemp genetics, was selected in mg Magazine’s 50 Best Companies to Work for in Cannabis. mg […]
LINCOLN, Neb.: LINCOLN, Neb., Dec. 21, 2021 /PRNewswire-PRWeb/ — Cambium Carbon, with support from The Nature Conservancy and the Arbor Day Foundation, released its Reforestation Hub assessment reports for three pilot cities — New York […]
What do the data so far tell us about Omicron and whether it causes milder disease than previous Covid-19 variants? What can we expect to see as Omicron infections crash up against the country’s health […]
SEATTLE: SEATTLE, Dec. 23, 2021 /PRNewswire/ — Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, today published research describing LMN-201, an investigational orally delivered biologic cocktail to prevent C. difficile […]
Copyright © 2022 Biotech Networks, LLC
